Sigma Healthcare Limited (ASX:SIG)
Australia · Delayed Price · Currency is AUD | Market Cap | 29.45B -14.7% |
| Revenue (ttm) | 10.83B +80.5% |
| Net Income | 709.18M +33.8% |
| EPS | 0.06 +21.9% |
| Shares Out | 11.50B |
| PE Ratio | 41.52 |
| Forward PE | 33.93 |
| Dividend | 0.04 (1.56%) |
| Ex-Dividend Date | Sep 3, 2026 |
| Volume | 7,730,320 |
| Open | 2.560 |
| Previous Close | 2.560 |
| Day's Range | 2.540 - 2.580 |
| 52-Week Range | 2.470 - 3.200 |
| Beta | 0.32 |
| Analysts | Buy |
| Price Target | 3.20 (+25.0%) |
| Est. Earnings | Nov 26, 2026 |
About Sigma Healthcare
Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies in Australia, and internationally. It is involved in the wholesale distribution of pharmaceutical, medical, healthcare and beauty products to a network of franchised retail pharmacies, and other third parties; advertising and marketing services; and provision of support services to a network of retail pharmacies. The company also provides MPS Connect, a end-to-end medication management solution. The company oper... [Read more]
Financial Performance
In fiscal year 2026, Sigma Healthcare's revenue was 10.83 billion, an increase of 80.53% compared to the previous year's 6.00 billion. Earnings were 709.18 million, an increase of 33.83%.
Financial StatementsAnalyst Summary
According to 16 analysts, the average rating for SIG stock is "Buy." The 12-month stock price target is $3.20, which is an increase of 25.00% from the latest price.
News
Chemist Warehouse lays out pathway to 100 stores as sales growth rises 20%
Chemist Warehouse's parent company Sigma Healthcare presented its result on Thursday.
Sigma Healthcare Earnings Call Transcript: H2 2026
Revenue rose 15.5% to AUD 10.8 billion, with EBIT and NPAT up over 20% and 22% respectively, driven by strong domestic and international growth, margin discipline, and synergy capture. FY27 outlook remains positive with continued store expansion and double-digit sales growth expected.
Sigma Healthcare Annual report: H2 2026
Sigma Healthcare has published its H2 2026 annual report on August 26, 2026.
Sigma Healthcare Earnings release: H2 2026
Sigma Healthcare released its H2 2026 earnings on August 26, 2026, summarizing the period's financial results.
Sigma Healthcare Slides: H2 2026
Sigma Healthcare has posted slides in relation to its H2 2026 quarterly earnings report, which was published on August 26, 2026.
Sigma Healthcare stock jumps 8% after pulling out of billion-dollar Boots deal
Sigma Healthcare stock jumped on Monday after the Australian pharmacy group walked away from a potential deal to buy UK pharmacy chain Boots. The development looks like a rare case of investors reward...
Australia's Sigma Healthcare drops pursuit of UK pharmacy chain Boots
Australia's Sigma Healthcare said on Monday it had walked away from preliminary talks to buy British pharmacy chain Boots, concluding that a potential deal would not meet its strategic and capital...
Sigma Healthcare in preliminary discussions to buy Boots
The company said, “Sigma Healthcare (SIGGF) refers to the recent media speculation regarding the sale process of The Boots Group. Sigma continuously reviews opportunities that would create value for s...
Sigma Healthcare in Preliminary Talks to Buy U.K.'s Boots
Australia's Sigma Healthcare said it is involved in early discussions about a potential acquisition of U.K. drugstore chain Boots.
Sigma Healthcare initiated with a Sector Perform at RBC Capital
RBC Capital analyst Michael Toner initiated coverage of Sigma Healthcare (SIGGF) with a Sector Perform rating and A$2.50 price target The firm cites risks from the company’s early international expans...
Sigma Healthcare Earnings Call Transcript: H1 2026
Revenue grew 15% year-over-year, with strong domestic and international sales, and normalized EBIT up 18.7%. Integration synergies and disciplined cost control supported margin expansion, while GLP-1 medicines drove significant sales growth.
Sigma Healthcare Quarterly report: H1 2026
Sigma Healthcare has published its H1 2026 quarterly earnings report on February 25, 2026.
Sigma Healthcare Slides: H1 2026
Sigma Healthcare has posted slides in relation to its H1 2026 quarterly earnings report, which was published on February 25, 2026.
Sigma Healthcare Earnings release: H1 2026
Sigma Healthcare released its H1 2026 earnings on February 25, 2026, summarizing the period's financial results.
Sigma Healthcare initiated with a Buy at Goldman Sachs
Goldman Sachs initiated coverage of Sigma Healthcare (SIGGF) with a Buy rating and A$3.50 price target The firm sees upside the company’s margin estimates and the stock’s valuation. Published first…
Sigma Healthcare Transcript: AGM 2025
The AGM highlighted strong financial growth post-merger, upgraded synergy targets, and robust governance enhancements. Shareholders approved all resolutions, including director reelections and remuneration reports, while the board addressed integration, remuneration, and related party governance in detail.
Sigma Healthcare Slides: FY 2025
Sigma Healthcare has posted slides in relation to its FY 2025 quarterly earnings report, which was published on October 21, 2025.
Sigma Healthcare Earnings Call Transcript: H2 2025
Strong post-merger results with revenue up 82% and normalized EBIT up 41%. Store network expansion, own brand growth, and upgraded synergy targets drive performance, while integration and competitive pressures remain key focus areas.
Sigma Healthcare Annual report: H2 2025
Sigma Healthcare has published its H2 2025 annual report on September 8, 2025.
Sigma Healthcare Slides: H2 2025
Sigma Healthcare has posted slides in relation to its H2 2025 quarterly earnings report, which was published on September 8, 2025.
Sigma Healthcare Earnings release: H2 2025
Sigma Healthcare released its H2 2025 earnings on September 8, 2025, summarizing the period's financial results.
Sigma Healthcare Slides: Company Presentation
Sigma Healthcare has posted slides in relation to its latest quarterly earnings report, which was published on May 5, 2025.
Sigma Healthcare Press release: Trading Update
Sigma Healthcare issued a press release on May 5, 2025, disclosing material business information to investors.
Sigma Healthcare initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Lisa Deng initiated coverage of Sigma Healthcare (SIGGF) with a Neutral rating and A$2.70 price target The firm views Sigma as a vertically integrated retail pharmacy leader…
Sigma Healthcare Transcript: EGM 2025
Shareholders approved key resolutions for a transformative merger with Chemist Warehouse, including new board appointments, governance frameworks for related party transactions, and changes to executive equity plans. The merger aims to create a leading pharmacy group with significant cost synergies and growth opportunities.